TUDOR INVESTMENT CORP ET AL - CADENCE PHARMACEUTICALS INC ownership

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 3 filers reported holding CADENCE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$151,000
-21.8%
16,706
-45.6%
0.01%
-12.5%
Q3 2013$193,00030,7000.01%
Other shareholders
CADENCE PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
OMNI PARTNERS LLP 250,000$3,500,0005.20%
BlackRock Institutional Trust Company, N.A. 6,178$86,0000.00%
CITIGROUP INC 13,052$183,0000.00%
View complete list of CADENCE PHARMACEUTICALS INC shareholders